DK1568356T3 - Prevention of tooth erosion using a colostrum protein - Google Patents

Prevention of tooth erosion using a colostrum protein

Info

Publication number
DK1568356T3
DK1568356T3 DK04075573T DK04075573T DK1568356T3 DK 1568356 T3 DK1568356 T3 DK 1568356T3 DK 04075573 T DK04075573 T DK 04075573T DK 04075573 T DK04075573 T DK 04075573T DK 1568356 T3 DK1568356 T3 DK 1568356T3
Authority
DK
Denmark
Prior art keywords
dental
prevention
colostrum protein
tooth erosion
erosion
Prior art date
Application number
DK04075573T
Other languages
Danish (da)
Inventor
Jorgen Christoffersen
Allan Bardow
Svend Kirkeby
Dennis Moe
Margaret Christoffersen
Brigitte Nauntofte
Anne Marie Pedersen
Original Assignee
Sara Lee De Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sara Lee De Nv filed Critical Sara Lee De Nv
Application granted granted Critical
Publication of DK1568356T3 publication Critical patent/DK1568356T3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20Milk; Whey; Colostrum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention relates dental care and in particular to the use of a dental care product for preventing, or reducing dental erosion. In accordance with the invention it has been found that dental erosion, which is defined as the loss of dental tissue as a result of chemical processes not involving bacteria, may be reduced of prevented by use of a dental care product comprising a colostrum protein.
DK04075573T 2004-02-24 2004-02-24 Prevention of tooth erosion using a colostrum protein DK1568356T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04075573A EP1568356B1 (en) 2004-02-24 2004-02-24 Prevention of dental erosion by use of a colostrum protein

Publications (1)

Publication Number Publication Date
DK1568356T3 true DK1568356T3 (en) 2009-07-06

Family

ID=34746032

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04075573T DK1568356T3 (en) 2004-02-24 2004-02-24 Prevention of tooth erosion using a colostrum protein

Country Status (6)

Country Link
EP (1) EP1568356B1 (en)
AT (1) ATE427111T1 (en)
DE (1) DE602004020315D1 (en)
DK (1) DK1568356T3 (en)
ES (1) ES2325074T3 (en)
PT (1) PT1568356E (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU411533B2 (en) * 1965-03-24 1971-03-08 The Colonial Sugar Refining Company Limited Compositions of matter containing complex cariostatic agents
JPH0253716A (en) * 1988-08-18 1990-02-22 Lion Corp Composition for oral cavity application
ATE227557T1 (en) * 1995-04-28 2002-11-15 Sara Lee De Nv USE OF DENTAL CARE PRODUCTS CONTAINING BOVINE COLOSTRUM
FI20010845A (en) * 2001-02-01 2002-08-02 Oulun Yliopisto A method for producing an enzyme from a new source

Also Published As

Publication number Publication date
ES2325074T3 (en) 2009-08-25
DE602004020315D1 (en) 2009-05-14
EP1568356B1 (en) 2009-04-01
PT1568356E (en) 2009-06-02
ATE427111T1 (en) 2009-04-15
EP1568356A1 (en) 2005-08-31

Similar Documents

Publication Publication Date Title
ATE534391T1 (en) 3,11B-CIS-DIHYDROTETRABENAZINE FOR THE TREATMENT OF PSYCHOSES
ATE489957T1 (en) AGENTS FOR THE TREATMENT OF INFLAMMATORY DISEASES
DK1545587T3 (en) Lactoferrin compositions and methods for the treatment of diabetic wounds
DK1446136T3 (en) Curcuminoid compositions with synergistic inhibition of the expression and / or activity of cyclooxygenase-2 gene
EP1753777A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF HIV INFECTION USING TRIM5a
DE602005019319D1 (en) COMPOSITIONS WITH ORNITHIN AND PHENYL ACETATE OR PHENYLBUTYRATE FOR THE TREATMENT OF HEPATIC ENZEPHALOPATHY
IL173002A (en) Use of calcitonin in the manufacture of an oral medicament for preventing or treating osteoarthritis
MA28935B1 (en) PREPARATION AND USE OF BIPHENYL-4-YL CARBONYLAMINO ACID DERIVATIVES IN THE TREATMENT OF OBESITY
DK1774972T3 (en) Use of selenium yeast in the treatment of Alzheimer's disease
DE602005019247D1 (en) USE OF CYCLODEXTRIN FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY BRONCHIAL DISEASES
CY1112116T1 (en) METHOD OF PATIENTS 'TREATMENT OF PATIENTS C
DE602005019341D1 (en) System for the treatment of sterilization cassettes with visual dual-code reader
WO2009130615A3 (en) Use of deuterium oxide as an elastase inhibitor
ATE504297T1 (en) VISNADIN FOR THE TREATMENT OF ITCH OF THE SCALP
DE602005016141D1 (en) S-MIRTAZAPINE FOR THE TREATMENT OF HITZEWALLUNGEN
NO20076405L (en) Use of 24-nor-UDCA
DE602005013650D1 (en) PROTEIN HYDROLYSATE FOR THE TREATMENT OF TIREDNESS
DE60333205D1 (en) HISTAMINIKA FOR THE TREATMENT OF ALLERGIC RHINITIS
ATE420089T1 (en) SUBSTITUTED AZACHINAZOLINES WITH ANTIVIRAL EFFECT
DE602005015434D1 (en) MEANS FOR THE TREATMENT OF PSYCHONEUROTIC DISEASES
ATE406171T1 (en) APLIDINE FOR THE TREATMENT OF MULTIPLE MYELOMA
DE60128009D1 (en) USE OF SARP-1 FOR THE TREATMENT AND / OR PREVENTION OF SCLERODERMA
DK1568356T3 (en) Prevention of tooth erosion using a colostrum protein
DE602005000442D1 (en) Use of alpha-1-antitrypsin for the manufacture of a medicament for the treatment of fibromyalgia
DE10394347T5 (en) A synergistic composition for the treatment of hyperlipidemia